Related Experiment Video
Updated: May 6, 2026
07:20
Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
40.0K
Statistical and practical considerations for clinical evaluation of predictive biomarkers
Mei-Yin C Polley1, Boris Freidlin, Edward L Korn
1Affiliations of authors: Biometric Research Branch (M-YCP, BF, ELK, LMS), Cancer Diagnosis Program (BAC), and Cancer Treatment and Evaluation Program (JSA), Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Journal of the National Cancer Institute
|October 19, 2013
Summary
Designing and interpreting predictive biomarker studies is crucial for precision medicine in cancer care. This includes assessing biomarker effects, sample size needs, and the clinical utility of biomarker-guided therapies.
Area of Science:
- Oncology
- Translational Medicine
- Biostatistics
Background:
- Precision medicine relies on predictive biomarkers to personalize cancer therapy.
- Effective use of biomarkers requires robust study design and interpretation.
- Biomarker studies inform treatment decisions for individual patients.
Purpose of the Study:
- To outline key considerations for designing and interpreting predictive biomarker studies in oncology.
- To address challenges in assessing predictive biomarker effects and clinical utility.
- To guide the application of biomarkers in clinical practice and research.
Main Methods:
- Discussion of principles for differentiating qualitative and quantitative predictive effects.
- Analysis of sample size requirements for reliable biomarker assessment.
- Inclusion of factors for clinical utility assessment, including therapy and test-related costs and toxicities.
Main Results:
- Highlights the importance of distinguishing between different types of predictive effects.
- Identifies sample size as a critical factor influencing biomarker study power.
- Emphasizes a comprehensive approach to clinical utility beyond mere predictive accuracy.
Conclusions:
- Well-designed predictive biomarker studies are essential for advancing precision oncology.
- Careful consideration of statistical and clinical factors ensures the reliable application of biomarkers.
- Integrating biomarker data with treatment costs and toxicity improves therapeutic decision-making.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
631
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
631
01:13Sensitivity, Specificity, and Predicted Value
1.9K
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
Sensitivity is the...
1.9K
01:16Clinical Trials
8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.5K
01:20Biostatistics: Overview
1.2K
Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...
Discrete variables are...
1.2K
01:19Overview of Biostatistics in Health Sciences
4.8K
Biostatistics involves the application of statistical techniques to scientific research in health-related fields, including biology and public health. These techniques are essential for designing studies, collecting data, and analyzing it to draw meaningful conclusions. Given the complexity of biological processes, particularly in studies involving human subjects, biostatistical methods are crucial for effectively organizing and interpreting data that might otherwise obscure underlying patterns...
4.8K
01:16Bioequivalence Data: Statistical Interpretation
358
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
358